Related Experiment Video

Updated: Jun 16, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

2.2K

Blap-6, a Novel Antifungal Peptide from the Chinese Medicinal Beetle Blaps rhynchopetera against Cryptococcus

La-Mei Zhang1,2, Sheng-Wen Zhou3,4, Xiao-Shan Huang3,4

  • 1Institute of Highland Forest Science, Chinese Academy of Forestry, Kunming 650224, China.

International Journal of Molecular Sciences
|May 25, 2024
PubMed

Insights

A novel antimicrobial peptide, blap-6, shows potent antifungal activity against Cryptococcus neoformans. This peptide disrupts fungal cell membranes and has low toxicity, offering a promising new therapeutic candidate for fungal infections.

Area of Science:

  • Mycology
  • Pharmacology
  • Biochemistry

Background:

  • Cryptococcus neoformans causes life-threatening meningitis, especially in immunocompromised individuals.
  • Current treatments like amphotericin B and azoles have significant toxicity.
  • New antifungal agents with improved safety profiles are urgently needed.

Purpose of the Study:

  • To identify and characterize novel antimicrobial peptides from Blaps rhynchopetera for potential antifungal drug development.
  • To evaluate the efficacy and mechanism of action of blap-6 against Cryptococcus neoformans.

Main Methods:

  • Screening of antimicrobial peptides from the hemolymph transcriptome of Blaps rhynchopetera.
  • Determination of minimum inhibitory concentration (MIC) and antifungal kinetics of blap-6.
  • Mechanistic studies involving fungal cell membrane integrity.
  • Assessment of hemolytic and cytotoxic effects on human cells.

Main Results:

  • Identified blap-6, a 17-amino acid peptide with potent activity against Cryptococcus neoformans (MIC = 0.81 μM).
  • Blap-6 demonstrated strong antifungal kinetics, disrupted fungal cell membranes, and inhibited biofilm formation.
  • The peptide exhibited low hemolytic and cytotoxic effects on human cells.

Conclusions:

  • Blap-6 is a potent antifungal agent against Cryptococcus neoformans with a novel mechanism of action.
  • Its low toxicity and biofilm inhibitory properties make it a promising candidate for developing new antifungal therapies.
  • Further research into blap-6 could lead to improved treatments for invasive fungal infections.
Keywords:
Blaps rhynchopeteraCryptococcus neoformansantimicrobial peptideblap-6

More Related Videos

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

1.1K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.9K

Related Concept Videos

Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...